3D Printing, Medical Models, Intellectual Property, and the FDA: Expert Gathering at Additive Manufacturing Strategies Summit
While adding more events to an already packed calendar year in technology can seem to be a tricky proposition, it takes differentiation and careful curation for any new happening to truly stand out — and this is why we worked with the diligent team at SmarTech Markets Publishing to put on this week’s Additive Manufacturing Strategies summit. The inaugural event for this hopefully long-lived new endeavor, the AMS summit held in Washington, D.C. focused on the future of 3D printing in medical and dental industries through a lens of legal strategy. The agenda was filled with experts in medicine, dentistry, intellectual property, and government regulation, and for two days more than 80 attendees packed the Army and Navy Club to hear and share ideas.
In welcoming attendees to the event, SmarTech President Lawrence Gasman said:
“Why this conference? It makes sense to narrow down the sectors 3D printing is involved with, the biggest being automotive, aerospace, medical; we think medical is a special case from the others. Indeed, medical may be the biggest when you take everything into consideration. With dental, very large volumes are already being manufactured. It is very different from the others as to regulations, and over these two days we’ll hear how that’s impacting devices, organs, and more.”
He noted that day one of the event was “of course a very unusual day in Washington,” as it was the Monday of the federal government’s shutdown; still, protocols in place did allow for a scheduled representative from the US FDA to be present to discuss the recently issued federal guidance regarding 3D printed medical devices, which is impacting the business of additive manufacturing. Gasman continued, noting that, “We wanted to crowd in as much medical 3D printing as we could.” Also speaking in welcome at the kickoff were Alan Meckler, President of 3DR Holdings, and myself on behalf of 3DPrint.com and our editorial staff.
The presentations began with an inspired keynote from Lee Dockstader, Director of Vertical Market Development, HP Inc., who shared thoughts on how 3D printing sees “applications in healthcare that are literally head to toe.” Touching as well on HP’s upcoming offerings in metal and full-color plastic 3D printing as they will relate to medical uses, Dockstader painted a vivid picture of increasing mainstream adoption for digital technologies in healthcare. On day two of the summit, a keynote from Katie Weimer, VP Medical Devices, 3D Systems, set the tone with a reflecton on the breadth of real-world applications, noting that “3D printing is at an inflection point in healthcare.”
“3D printing really does play a role in the promise of this precision medicine,” Weimer said. “It really allows for the adoption of that patient-specific solution.”
Precise, personalized care is the promise for bringing advanced technologies into the healthcare arena, and the many examples showcased across the two days served as indicators of not only what has emerged already — such as the very-well defined use of 3D printing in the production of orthodontic aligners and of hearing aids — but ideas of what will hit the market in both the near term and in a longer-term future. In addition to the keynotes, we heard from SmarTech analysts for market projections and from several expert panels across a variety of topics, from prosthetics to intellectual property to bioprinting to dentistry.
Hailing from hospitals, from academia, and from the companies actively developing these capabilities, as well as from legal backgrounds, the speakers throughout the agenda were optimistic about the place of additive manufacturing in the future of human care without veering into the wilderness of postulation. Each future advance was well grounded in a world of established capabilities, and far-off advances — most notably the potential of bioprinting entire human organs for implantation — were viewed through a lens of careful consideration and the necessity for step-by-step approaches.
We’ll have more detail soon from the thoughtful content of the summit, as well as exclusive interviews with representatives from the FDA and a leading law firm focusing on IP in 3D printing. Events such as the Additive Manufacturing Strategies summit serve as a gathering place for not only the like-minded, but the informed in deep matters of both technology and policy, providing an invaluable experience. Following the success of this first event, we look forward to welcoming more in thought leadership and networking opportunity at Additive Manufacturing Strategies events.
Discuss events and other 3D printing topics at 3DPrintBoard.com, or share your comments below.[All images: Sarah Goehrke]
You May Also Like
3DPOD Episode 14: Consumer and Affordable 3D Printers
This 3DPod Episode is filled with opinion. Here we look at our favorite affordable desktop 3D printers. We evaluate what we want to see in a printer and how far...
3D Printer Buying Guide 2019
What a difference a year makes. Once again we’ve seen some monumental shifts and changes in the 3D printing landscape for desktop 3D printers. At the low-end competition has been...
Prusa Publishes Hardware and Firmware Updates for 3D Printers, Ships over 130,000 Printers
It’s time for another one of Prusa‘s popular updates on its various hardware and firmware! The company makes sure its customers always know about the latest new products and improvements to its...
The Nydus One Syringe Extruder (NOSE): Turns Your Prusa i3 Into a Bioprinter
Researchers from Germany are exploring democratizing bioprinting with their findings outlined in ‘Nydus One Syringe Extruder (NOSE): A Prusa i3 3D printer conversion for bioprinting applications.’ Recognizing the promise of...
View our broad assortment of in house and third party products.